Wu, Y <br/><br/>
1 alpha,25-Dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells.  [electronic resource] 

 -  Biochemical and biophysical research communications  Oct 1997 
 - 734-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-291X 
<br/><br/><label>Standard No.: </label>10.1006/bbrc.1997.7544  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activin Receptors, Type I<br/>Antibodies--pharmacology<br/>Calcitriol--antagonists & inhibitors<br/>Cell Line<br/>Cell-Free System<br/>Dose-Response Relationship, Drug<br/>Fetus<br/>Growth Inhibitors--antagonists & inhibitors<br/>Growth Substances--metabolism<br/>Humans<br/>Osteoblasts--cytology<br/>Protein Serine-Threonine Kinases--biosynthesis<br/>RNA, Messenger--drug effects<br/>Receptor, Transforming Growth Factor-beta Type I<br/>Receptor, Transforming Growth Factor-beta Type II<br/>Receptors, Transforming Growth Factor beta--biosynthesis<br/>Transcription, Genetic--drug effects<br/>Transforming Growth Factor beta--biosynthesis